Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Get Free Report)’s share price rose 5.4% during mid-day trading on Monday . The company traded as high as $101.36 and last traded at $100.45. Approximately 691,640 shares traded hands during trading, a decline of 53% from the average daily volume of 1,470,370 shares. The stock had previously closed at $95.33.
Direxion Daily S&P Biotech Bull 3x Shares Stock Up 3.8 %
The firm’s fifty day simple moving average is $101.69 and its 200 day simple moving average is $120.24.
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of LABU. Thurston Springer Miller Herd & Titak Inc. acquired a new position in Direxion Daily S&P Biotech Bull 3x Shares in the 3rd quarter valued at approximately $43,000. Dunhill Financial LLC bought a new position in Direxion Daily S&P Biotech Bull 3x Shares during the 3rd quarter worth $46,000. Spire Wealth Management acquired a new position in Direxion Daily S&P Biotech Bull 3x Shares during the 4th quarter worth about $68,000. B. Riley Wealth Advisors Inc. bought a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares in the 3rd quarter valued at about $279,000. Finally, SG Americas Securities LLC increased its stake in shares of Direxion Daily S&P Biotech Bull 3x Shares by 6.0% in the fourth quarter. SG Americas Securities LLC now owns 3,392 shares of the company’s stock valued at $305,000 after buying an additional 193 shares during the period.
Direxion Daily S&P Biotech Bull 3x Shares Company Profile
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
See Also
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- What Does a Stock Split Mean?
- Sizing Up a New Opportunity for NVIDIA Investors
- Upcoming IPO Stock Lockup Period, Explained
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- The 3 Biggest M&A Stock Opportunities for 2025
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.